Key result
In adults with type 2 diabetes and ASCVD, having multiple affected vascular beds increased mean annual healthcare costs from $17,741 (1 bed) to $25,877 (2 beds) and $33,412 (3 beds).
Why the study?
The study was conducted to evaluate the prevalence of ASCVD by number of affected vascular beds and assess its impact on healthcare utilization and costs in patients with type 2 diabetes.
Does the number of affected vascular beds impact healthcare utilization and costs in adults with type 2 diabetes and established ASCVD?
Cross-Sectional (n=539,089)
Does the number of affected vascular beds impact healthcare utilization and costs in adults with type 2 diabetes and established ASCVD?
In patients with type 2 diabetes and ASCVD, polyvascular disease is highly prevalent (47%) and drives a stepwise increase in healthcare costs, particularly in younger patients.
No takes yet. Share an insight, caveat, or question.
Higher costs with polyvascular disease in T2D-ASCVD; extends burden data but leaves open whether bed-targeted strategies reduce utilization.
Weng et al. (2020) conducted a cross-sectional in Type 2 diabetes mellitus and established ASCVD (n=539,089). Multiple ASCVD-affected vascular beds vs. 1 affected vascular bed was evaluated on Mean annual total healthcare costs per person. In adults with type 2 diabetes and ASCVD, having multiple affected vascular beds increased mean annual healthcare costs from $17,741 (1 bed) to $25,877 (2 beds) and $33,412 (3 beds).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: